Skip to content

Interventional Efficacy of Transcranial Temporal Interference Stimulation for Adolescent Depressive Disorder Comorbid with Internet Addiction

Interventional Efficacy of Transcranial Temporal Interference Stimulation for Adolescent Depressive Disorder Comorbid with Internet Addiction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119268
Enrollment
Unknown
Registered
2026-02-25
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent MDD and Internet Addiction

Interventions

Real group:The stimulation frequency is an envelope frequency of 10Hz, with a treatment duration of 10 days, a current intensity of 2mA, and a duration of 30 min
Sham group:The current intensity is 2mA, with a duration of 1 minute (rising for 30 seconds and falling for 30 seconds) to simulate a real-life stimulation exper

Sponsors

Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 12 and 18 years; 2.Meet the MDD and Internet Addiction diagnostic criteria for DSM-V; 3.Right-handed; 4.Routine blood, electrocardiogram indicators are all normal; 5.After fully understanding the safety of transcranial electrical stimulation, I am willing to actively cooperate with the treatment and have both myself and my family sign informed consent;

Exclusion criteria

Exclusion criteria: (1) age 18 years old; (2) history of serious physical diseases; (3) patients with metal or electronic instruments, such as intracranial metal foreign bodies, cochlear implants, cardiac pacemakers and stents; (4) patients with risk of epilepsy, previous craniocerebral disease, head trauma, abnormal electroencephalogram, MRI evidence of brain structural abnormalities, or family history of epilepsy; (5) using neuroelectrophysiological drugs or antipsychotic drugs; (6) patients who received other physical therapy recently

Design outcomes

Primary

MeasureTime frame
IAT?HAMD-24?HAMA?BIS-11;

Secondary

MeasureTime frame
Resting-state cerebral functional magnetic resonance imaging;Neuropsychological tests;

Countries

China

Contacts

Public ContactWenwu Zhang

Affiliated Kangning Hospital of Ningbo University

knyyzww@163.com+86 574 26302565

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026